clinical

default-18

Clinical trials and the vital role they play in furthering cancer research

(BPT) – The world of health care is one of constant innovation and discovery. New drugs, treatments and ideas are needed to combat the various health problems Americans face every single day. It is an ever-evolving challenge, and as health concerns are conquered, one constant threat remains: Cancer. According to the American Society of Clinical […]

Continue Reading
default-4

Taking the Mystery Out of Cancer Clinical Trials

(BPT) – In 2012, Donna Fernandez was diagnosed with stage 4 lung cancer-a disease that claims the lives of more than 150,000 men and women in the United States each year. She went through multiple rounds of various medicines, but her disease progressed. Her doctor offered her a choice: start a new chemotherapy regimen or […]

Continue Reading
default-20

Sore knees? 3 reasons to participate in a clinical trial

(BPT) – Designed to evaluate the safety and effectiveness of new treatments, clinical trials are the only way medical advances can move knowledge and science forward. In regard to knee pain, clinical trials offer the newest and latest ideas on finding better ways to treat pain. People participate in clinical trials for a variety of […]

Continue Reading
rp_ancrd5608.gif

First pharmacological guideline for obesity treatment provides clinical roadmap for anti-obesity drug treatment

The first-ever clinical practice guideline for the drug treatment of obesity offers a new tool for health practitioners looking to the latest pharmacotherapy strategies as a means of treating patients with obesity. The release comes on the heels of U.S. Food and Drug Administration (FDA) approval of four new anti-obesity drugs in the past two […]

Continue Reading

Poor diuretic response associated with worse clinical outcomes

Poor diuretic response is associated with worse in-hospital and post-discharge clinical outcomes, results of the RELAX-AHF trial reveal. The study also found that serelaxin has a neutral effect on diuretic response. These novel data from the RELAX-AHF trial were presented by lead author Professor Adriaan A. Voors at the Heart Failure Congress 2014, held 17-20 […]

Continue Reading